Gainers
- Virax Biolabs Group Limited (NASDAQ:VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.
- Addex Therapeutics Ltd (NASDAQ:ADXN) gained 110.4% to close at $1.93 after the company issued corporate update and financial guidance. The company announced the reduction of its issued, authorized and conditional share capital from CHF 1.00 to CHF 0.01 and provided corporate updates.
- 1Life Healthcare, Inc. (NASDAQ:ONEM) gained 69.5% to close at $17.25 after Amazon announced it will acquire the company for $18 per share in an all-cash transaction valued at approximately $3.9 billion.
- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) shares jumped 56.5% to close at $4.07 after the company said it expects Q2 sales of $72 – $73 million, exceeding the prior guidance range of $66 – $69 million and the consensus of $67.61 million.
- Tuesday Morning Corporation (NASDAQ:TUEM) rose 42.8% to close at $0.2838 after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for customized location intelligence solutions.
- ToughBuilt Industries, Inc. (NASDAQ:TBLT) climbed 36.5% to close at $5.72.
- Vertical Aerospace Ltd. (NASDAQ:EVTL) gained 34.3% to close at $8.07. Strength was possibly due to continued momentum after the company announced an order for its VX4 aircrafts last week. The company also announced a partnership to explore new variants for the VX4.
- Skylight Health Group Inc. (NASDAQ:SLHG) rose 26.5% to close at $0.6450.
- Entera Bio Ltd. (NASDAQ:ENTX) gained 25.2% to settle at $1.89.
- Pintec Technology Holdings Limited (NASDAQ:PT) gained 25.1% to close at $1.11.
- MoonLake Immunotherapeutics (NASDAQ:MLTX) gained 25% to close at $6.91 after HC Wainwright & Co. initiated coverage on the stock with a Buy rating and a $28 price target.
- Phunware, Inc. (NASDAQ:PHUN) jumped 24.8% to close at $1.76.
- Kaltura, Inc. (NASDAQ:KLTR) gained 23.7% to settle at $2.56.
- Altice USA, Inc. (NASDAQ:ATUS) gained 22.3% to settle at $11.23 following a report suggesting the company is said to weigh a Suddenlink sale for up to $20 billion.
- Belite Bio, Inc (NASDAQ:BLTE) jumped 22.1% to close at $41.51.
- LightPath Technologies, Inc. (NASDAQ:LPTH) surged 21.5% to close at $1.75.
- SkyWater Technology, Inc. (NASDAQ:SKYT) gained 21.3% to close at $13.16.
- Evofem Biosciences, Inc. (NASDAQ:EVFM) rose 20.7% to close at $1.00. Evofem partnered with A360 media to support Phexxi prescription growth.
- Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) gained 20.6% to close at $5.68 after the FDA granted Fast Track designation to OP-1250, the company's oral complete estrogen receptor antagonist and selective ER degrader.
- Datasea Inc. (NASDAQ:DTSS) rose 20% to close at $2.22. Datasea’s subsidiary Guohao Century (Beijing) Technology recently inked a purchase agreement with Hangzhou Runsheng Network Technology Ltd, a leading marketing service provider, for a consideration of $22.3 million (RMB 150 million).
- Acutus Medical, Inc. (NASDAQ:AFIB) gained 18.7% to close at $1.65. Acutus Medical appointed David Roman as President and CEO. The company also said it sees preliminary Q2 sales of $4 million to $4.1 million.
- Nymox Pharmaceutical Corporation (NASDAQ:NYMX) surged 18.1% to close at $0.36.
- Standard Lithium Ltd. (NYSE:SLI) jumped 18% to settle at $5.44.
- ATA Creativity Global (NASDAQ:AACG) gained 17.4% to settle at $1.62.
- Digital Media Solutions, Inc. (NYSE:DMS) jumped 17.3% to close at $1.49.
- Boxed, Inc. (NYSE:BOXD) gained 16.8% to close at $2.30.
- COMSovereign Holding Corp. (NASDAQ:COMS) gained 16.5% to close at $0.1658.
- Velo3D, Inc. (NYSE:VLD) gained 15.8% to close at $3.38.
- Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) rose 15.5% to close at $1.42.
- Expion360 Inc. (NASDAQ:XPON) gained 15.5% to settle at $3.36.
- Oyster Point Pharma, Inc. (NASDAQ:OYST) jumped 15.3% to settle at $6.39.
- Repligen Corporation (NASDAQ:RGEN) gained 15.3% to close at $203.64. UBS initiated coverage on Repligen with a Buy rating and announced a price target of $213.
- Cano Health, Inc. (NYSE:CANO) rose 13.8% to settle at $6.50.
- Super Micro Computer, Inc. (NASDAQ:SMCI) rose 13.3% to close at $51.63 after the company issued Q4 sales guidance above estimates.
- CareMax, Inc. (NASDAQ:CMAX) gained 12.1% to settle at $6.48.
- PARTS iD, Inc. (NYSE:ID) jumped 11.1% to close at $1.20. EF Hutton initiated coverage on PARTS iD with a Buy rating and announced a price target of $3.
- Tesla, Inc. (NASDAQ:TSLA) rose 9.8% to close at $815.12. Tesla posted better-than-expected earnings for its second quarter, while sales missed estimates. Second-quarter deliveries were 254,695, up 27% year-over-year.
- Danaher Corporation (NYSE:DHR) gained 9.1% to close at $279.23 after the company reported better-than-expected Q2 EPS and sales results.
- Nokia Oyj (NYSE:NOK) rose 8.9% to close at $5.12 after reporting upbeat Q2 profit.
- Bio-Rad Laboratories, Inc. (NYSE:BIO) gained 7.7% to settle at $534.41. Bio-Rad Laboratories is expected to report its financial results for the second quarter on Thursday, July 28, 2022.
- Agilent Technologies, Inc. (NYSE:A) surged 6.1% to settle at $127.19. UBS recently initiated coverage on Agilent Technologies with a Buy rating and announced a price target of $139.
- Philip Morris International Inc. (NYSE:PM) gained 4.2% to close at $93.59 after the company reported better-than-expected Q2 EPS and sales results and issued FY22 EPS guidance above estimates.
-
Losers
- LumiraDx Limited (NASDAQ:LMDX) shares tumbled 37% to close at $1.33 after the company reported pricing of public offering of common shares and concurrent private placement.
- NLS Pharmaceutics AG (NASDAQ:NLSP) fell 31.7% to close at $0.41. NLS Pharmaceutics announced positive opinion from European Regulators to grant orphan drug designation for Mazindol ER in idiopathic hypersomnia.
- Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) dropped 26.5% to close at $3.41.
- ProPhase Labs, Inc. (NASDAQ:PRPH) dipped 24.7% to close at $10.33. The company earlier announced a license agreement for its Linebacker portfolio, under which PBIO has obtained exclusive rights worldwide to develop and commercialize LB-1 and LB-2 for the treatment of multiple diseases.
- Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) declined 16.7% to close at $0.4015.
- 36Kr Holdings Inc. (NASDAQ:KRKR) dropped 16% to close at $0.9320.
- Insteel Industries, Inc. (NASDAQ:IIIN) fell 15.6% to close at $2.98 after the company posted weaker-than-expected Q3 results.
- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) fell 14.9% to close at $0.8336. Adial Pharmaceuticals shares dipped around 47% on Wednesday after the company announced topline results for its Onward Phase 3 trial for AD04 in patients with Alcohol Use Disorder.
- Pagaya Technologies Ltd. (NASDAQ:PGY) fell 13.7% to close at $5.35. Pagaya Technologies shares jumped around 130% on Wednesday on continued volatility after the company completed its SPAC merger agreement last month.
- Otonomy, Inc. (NASDAQ:OTIC) fell 12.1% to settle at $1.9350.
- Vascular Biogenics Ltd. (NASDAQ:VBLT) dipped 11.5% to close at $0.3761 after Chardan Capital downgraded the stock from Buy to Neutral.
- Sonder Holdings Inc. (NASDAQ:SOND) dropped 11.4% to settle at $1.01.
- Carnival Corporation (NYSE:CCL) fell 11.2% to close at $9.85 after the company priced its 102 million share offering at $9.95 per share.
- W&T Offshore, Inc. (NYSE:WTI) dropped 10.6% to close at $3.98.
- United Airlines Holdings, Inc. (NASDAQ:UAL) shares fell 10.2% to settle at $100.00 as the company posted weaker-than-expected earnings for its second quarter on Wednesday.
- Richardson Electronics, Ltd. (NASDAQ:RELL) dropped 9.8% to close at $15.24 following Q4 results.
- Applied Blockchain, Inc. (NASDAQ:APLD) fell 9.6% to close at $2.25 after gaining over 17% on Wednesday.
- Intelligent Living Application Group Inc. (NASDAQ:ILAG) dipped 9.2% to close at $2.66.
- Discover Financial Services (NYSE:DFS) dipped 8.9% to close at $100.00 following Q2 results.
- Evogene Ltd. (NASDAQ:EVGN) dropped 8.8% to close at $0.93.
- Verve Therapeutics, Inc. (NASDAQ:VERV) fell 8.6% to settle at $32.81 after the company announced a proposed $200 million public offering of common stock. Also, the company announced a collaboration with Vertex to discover and develop an in vivo editing program for liver disease.
- Stronghold Digital Mining, Inc. (NASDAQ:SDIG) fell 7.2% to close at $2.98 following a 50% surge on Wednesday.
